These findings suggested that rPR8-CCL19 could not only mediate the over-repression of CCL19 in CRC cells, which exhibited strong chemotactic effects on immune cells, but also activate immune cells in vitro. The gene discussed is CCL19; the disease is colorectal carcinoma.